Phase 3 Trial Backs Ivarmacitinib as Effective Oral Option for Moderate to Severe Atopic Dermatitis Medha Baranwal1 May 2025 9:15 PM ISTChina: A recent phase 3 randomized clinical trial has shown that ivarmacitinib significantly improves symptoms in adolescents and adults with moderate...
Rilzabrutinib could be effective treatment option in individuals with moderate to severe chronic spontaneous urticaria: JAMA Jacinthlyn Sylvia30 April 2025 8:15 PM ISTA new study published in the Journal of American Medical Association showed that Rilzabrutinib decreased itching and hives while preserving a positive...
Immune Checkpoint Inhibitors for Cancer Treatment Tied to Significant Reduction of Actinic Keratoses: JAMA Medha Baranwal17 March 2025 8:30 PM ISTAustralia: Researchers have found in a small study that immune checkpoint inhibitors (ICIs) used for cancer treatment significantly reduced actinic...
Low-dose minocycline hydrochloride effective in the treatment of papulopustular rosacea: JAMA Jacinthlyn Sylvia15 March 2025 7:45 AM ISTA new study published in the Journal of American Medical Association showed that patients with moderate to severe papulopustular rosacea responded...
HPV Vaccination Promising in Reducing Actinic Keratosis Burden: VAXAK Trial Findings Medha Baranwal9 March 2025 9:00 PM ISTDenmark: A recent randomized clinical trial, VAXAK, has highlighted the potential benefits of human papillomavirus (HPV) vaccination in managing...
Once-Daily Roflumilast Cream Shows Promising for Atopic Dermatitis: JAMA Dr Riya Dave13 Feb 2025 5:45 AM ISTA 0.15% once-daily roflumilast cream improved symptoms of atopic dermatitis (AD) across multiple endpoints, according to investigators of phase 3...
Baricitinib and UV-B phototherapy combination effective against severe vitiligo, reveals research Jacinthlyn Sylvia28 Jan 2025 8:30 PM ISTA recent clinical trial found that combining the oral medication baricitinib with narrowband UV-B light therapy significantly improves outcomes for...
Higher Cumulative Isotretinoin Dosages Linked to Lower Acne Relapse Rates, Study Finds Medha Baranwal18 Jan 2025 7:15 AM ISTUSA: A recent cohort study published in JAMA Dermatology has shed light on the potential benefits of optimizing isotretinoin treatment to reduce the...
Elevated C-Reactive Protein in Hidradenitis Suppurativa tied to Severe Disease and Reduced Adalimumab Efficacy: JAMA Medha Baranwal15 Jan 2025 8:45 PM ISTUSA: A recent post hoc analysis of two randomized clinical trials has provided insight into the role of C-reactive protein (CRP) as a potential...
New Clinical Trial Supports QX004N's Safety and Effectiveness for Patients With Plaque Psoriasis Medha Baranwal25 Dec 2024 8:30 PM ISTChina: A new randomized clinical trial has demonstrated that QX004N, a humanized anti-IL-23 monoclonal antibody, offers superior safety and efficacy...
Phase 3 Trial Confirms Nemolizumab's Efficacy for Moderate to Severe Prurigo Nodularis Medha Baranwal12 Dec 2024 8:30 PM ISTGermany: The OLYMPIA 1 Phase 3 randomized clinical trial has revealed promising outcomes for nemolizumab, a monoclonal antibody targeting...
JAMA Study Finds Deucravacitinib Effective and Safe for Psoriasis Patients Jacinthlyn Sylvia9 Dec 2024 8:00 PM ISTThis recent 3-year study revealed that deucravacitinib which is an oral treatment for moderate to severe plaque psoriasis to offer a sustainable and...
